Reuters logo
3 个月内
BRIEF-Gilead Sciences says Nova Scotia lists Epclusa on public drug plan to treat all six genotypes of Chronic Hepatitis C infection
2017年5月1日 / 中午11点41分 / 3 个月内

BRIEF-Gilead Sciences says Nova Scotia lists Epclusa on public drug plan to treat all six genotypes of Chronic Hepatitis C infection

1 分钟阅读

May 1 (Reuters) - Gilead Sciences Inc

* Gilead sciences inc - nova scotia lists epclusa on public drug plan to treat all six genotypes of chronic hepatitis c infection

* Effective immediately, nova scotia will provide public access to epclusa (sofosbuvir/velpatasvir) tablets Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below